logo

For the Inventor, By the Inventor

Baltimore, MD, United States of America

Gliknik Inc.


USPTO Granted Patents = 17



Trademarks = 1

Forward Citations = 146

Loading Chart...
Loading Chart...

5 inventors (with patents filed for the assignee):

goldMedal David S Block (17 out of 17 patents)

silverMedal Henrik Olsen (17 out of 17 patents)

bronzeMedal Scott E Strome (7 out of 21 patents)

4.  Dan H Schulze (7 out of 8 patents)

5.  Emmanuel Y Mérigeon (3 out of 3 patents)


17 patents:

1. 12337026 - Methods of treating inflammatory disorders with multivalent Fc compounds (2025-06-24),
2. 12195499 - Manufacturing optimization of GL-2045, a multimerizing stradomer (2025-01-14),
3. 12122836 - Fusion proteins of human protein fragments to create orderly multimerized immunoglobulin Fc compositions with enhanced complement binding (2024-10-22),
4. 12084482 - Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin Fc compositions (2024-09-10),
5. 11795193 - Manufacturing optimization of GL-2045, a multimerizing stradomer (2023-10-24),
6. 11331372 - Methods of treating inflammatory disorders with multivalent Fc compounds (2022-05-17),
7. 11155574 - Manufacturing optimization of GL-2045, a multimerizing stradomer (2021-10-26),
8. 11117940 - Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin Fc compositions (2021-09-14),
9. 11034775 - Cysteine-optimized stradomers (2021-06-15),
10. 10941191 - Immunoglobulin constant region Fc receptor binding agents (2021-03-09),
11. 10851154 - Immunoglobulin constant region Fc receptor binding agents (2020-12-01),
12. 10208105 - Immunoglobulin constant region Fc receptor binding agents (2019-02-19),
13. 9926362 - Immunoglobulin constant region Fc receptor binding agents (2018-03-27),
14. 9683044 - Molecules with antigen binding and polyvalent FC gamma receptor binding activity (2017-06-20),
15. 9512210 - Immunoglobulin constant region Fc receptor binding agents (2016-12-06),
Gliknik Inc. is a biopharmaceutical company focused on the discovery and development of novel therapies for the treatment of cancer and immune-related disorders. With a commitment to improving patient outcomes, Gliknik utilizes cutting-edge technologies to design innovative antibody therapeutics and vaccines. Their research and development efforts are centered around targeting specific immune system components to enhance the body's natural defenses against diseases. By harnessing the power of the immune system, Gliknik aims to revolutionize the way various diseases are treated, offering new hope to patients around the world.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

17 Patents

#28 in Baltimore, MD

#249 in Maryland

#18,297 in US

#34,825 in the World

...
Baltimore, MD, United States of America

Gliknik Inc.

Forward Citations = 146

5 inventors:

goldMedal David S Block (17 out of 17 patents)

silverMedal Henrik Olsen (17 out of 17 patents)

bronzeMedal Scott E Strome (7 out of 21 patents)

4.  Dan H Schulze (7 out of 8 patents)

5.  Emmanuel Y Mérigeon (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com
Loading…